Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
about
A Review of Safety and Design Requirements of the Artificial Pancreas.Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients.The artificial pancreas: current status and future prospects in the management of diabetes.Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.An integrated multivariable artificial pancreas control systemMultivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.A review of artificial pancreas technologies with an emphasis on bi-hormonal therapyModel-based closed-loop glucose control in type 1 diabetes: the DiaCon experienceSafety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.Physical activity and type 1 diabetes: time for a rewire?An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes."Turn it off!": diabetes device alarm fatigue considerations for the present and the future.Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.
P2860
Q28066687-CF6C3D46-0468-4AEB-8FF3-BAC99A515911Q30278498-8AB019B6-FC42-4BC5-A4EE-737192195718Q30370086-41E7BE16-35DD-46D9-84CB-27A54380B33DQ30409749-1060AE7B-7394-4585-9C43-C6BD3157F586Q33440813-A11D7A1B-C9A6-4EC5-8CCA-CBA5409E7310Q33786175-8DF000A7-3940-40E7-933D-85ED12BB6DAAQ34797693-973F4A53-072E-43AE-A3B5-52C0EE3449F7Q35682836-8437CE25-1976-4DED-9043-E3D8A060C569Q36813568-A4137EA2-8BC3-43A1-9111-598E38BDD19DQ37154369-8E97E345-4152-4C2C-8A87-16FE6A20B029Q37421657-E2EA7954-F329-403F-89DB-3E10AFDD13C4Q37597019-0E74E036-1498-49F2-BEC6-25289E56420FQ38310888-6B038996-2F7E-4BC1-93C3-14B1969CD82CQ38498029-EBA39903-FB22-4E81-84B0-9E97F4B4D77AQ39403563-CF929893-6BCB-4872-A27C-FAA8C2C17A21Q41458753-7F863135-DB5E-401D-ADCC-294B30777E44
P2860
Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safe glycemic management durin ...... tion for stress hyperglycemia.
@ast
Safe glycemic management durin ...... tion for stress hyperglycemia.
@en
type
label
Safe glycemic management durin ...... tion for stress hyperglycemia.
@ast
Safe glycemic management durin ...... tion for stress hyperglycemia.
@en
prefLabel
Safe glycemic management durin ...... tion for stress hyperglycemia.
@ast
Safe glycemic management durin ...... tion for stress hyperglycemia.
@en
P2093
P2860
P1476
Safe glycemic management durin ...... tion for stress hyperglycemia.
@en
P2093
Jessica R Castle
Joseph El Youssef
W Kenneth Ward
P2860
P304
P356
10.1177/193229681100500608
P577
2011-11-01T00:00:00Z